To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1

Status unconfirmed · Phase 1

Conditions studied: Amphetamine-Related Disorders

In brief

To assess the safety and tolerability of 7.5, 15 and 30 mg of sublingual lobeline.

Key facts

Study ID

NCT00100074

Run by

National Institute on Drug Abuse (NIDA)

People needed

8

Starts

2004-09-01

Expected to finish

2005-04-01

Last updated by the study team

2017-01-11

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy individuals with a body mass index between 18 and 30.
• Willing and able to give written consent.
• Must have a negative drug test
• Females must have a negative pregnancy test prior to study drug administration
• Must have no medical contraindications as determined by routine testing

You may not qualify if…

• Please contact the site for more information

Where it is running

• U of CA, San Francisco — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.